{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:01:18Z","timestamp":1790222478633,"version":"4.1.0"},"publisher-location":"Cham","reference-count":132,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783319938660","type":"print"},{"value":"9783319938677","type":"electronic"}],"license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.1007\/5584_2018_184","type":"book-chapter","created":{"date-parts":[[2018,3,19]],"date-time":"2018-03-19T06:14:15Z","timestamp":1521440055000},"page":"17-36","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Adult Stem Cells and Medicine"],"prefix":"10.1007","author":[{"given":"Sinem Civriz","family":"Bozda\u011f","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meltem Kurt","family":"Y\u00fcksel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taner","family":"Demirer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,20]]},"reference":[{"issue":"4","key":"184_CR1","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s00018-016-2306-y","volume":"74","author":"A Abel S\u00e1nchez-Aguilera","year":"2017","unstructured":"Abel S\u00e1nchez-Aguilera A, M\u00e9ndez-Ferrer S (2017) The hematopoietic stem-cell niche in health and leukemia. Cell Mol Life Sci 74(4):579\u2013590","journal-title":"Cell Mol Life Sci"},{"issue":"3","key":"184_CR2","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.bbmt.2008.11.036","volume":"15","author":"M Aglietta","year":"2009","unstructured":"Aglietta M, Barkholt L, Carnevale Schianca F et al (2009) On behalf of the EBMT solid tumor working party. Reduced intensity allogeneic hematopoietic stem cell transplantation in metastatic colorectal cancer as a novel adoptive cell therapy approach. The European group for blood and marrow transplantation experience. Biol Blood Marrow Transplant 15(3):326\u2013335","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"184_CR3","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1177\/0961203312470729","volume":"22","author":"B Alchi","year":"2013","unstructured":"Alchi B, Jayne D, Labopin M, et al. EBMT Autoimmune Disease Working Party members (2013) Autologous haematopoietic stem cell transplantation for systemic lupus erythematosus: data from the European group for blood and marrow transplantation registry. Lupus 22(3):245\u2013253","journal-title":"Lupus"},{"key":"184_CR4","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1023\/A:1026454831340","volume":"10","author":"J Aparicio","year":"1999","unstructured":"Aparicio J, Segura A, Garcera S et al (1999) ESHAP is an active regimen for relapsing Hodgkin\u2019s disease. Ann Oncol 10:593\u2013595","journal-title":"Ann Oncol"},{"key":"184_CR5","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.bbmt.2006.05.015","volume":"12","author":"AS Artz","year":"2006","unstructured":"Artz AS, Pollyea DA, Kocherginsky M et al (2006) Performance status and co-morbidity predict transplant-related mortality after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 12:954\u2013964","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"184_CR6","first-page":"239","volume":"26","author":"P Ataca","year":"2016","unstructured":"Ataca P, Atilla E, Toprak SK et al (2016) Non-infectious early complications of allogeneic stem cell transplantations. Int J Hematol\/Oncol 26(4):239\u2013250","journal-title":"Int J Hematol\/Oncol"},{"issue":"2","key":"184_CR7","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.transci.2016.11.005","volume":"56","author":"P Atilla Ataca","year":"2017","unstructured":"Atilla Ataca P, Mine OS, Demirer T (2017a) How to manage poor mobilizers for high dose chemotherapy and autologous stem cell transplantation? Transfus Apher Sci 56(2):190\u2013198","journal-title":"Transfus Apher Sci"},{"key":"184_CR8","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s15010-017-1016-1","volume":"45","author":"P Atilla Ataca","year":"2017","unstructured":"Atilla Ataca P, Atilla E, Bozda\u011f SC et al (2017b) A review of infectious complications after Haploidentical hematopoietic stem cell transplantations. Infection 45:403\u2013411","journal-title":"Infection"},{"issue":"1","key":"184_CR9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4274\/balkanmedj.2017.0055","volume":"34","author":"E Atilla","year":"2017","unstructured":"Atilla E, Atilla Ataca P, Demirer T (2017a) A review of Myeloablative vs reduced intensity\/non-Myeloablative regimens in allogeneic hematopoietic stem cell transplantations. Balkan Med J 34(1):1\u20139","journal-title":"Balkan Med J"},{"key":"184_CR10","doi-asserted-by":"crossref","unstructured":"Atilla E, Atilla Ataca P, Toprak SK et al (2017b) A review of late complications of allogeneic hematopoietic stem cell transplantations. Clin Transpl 31(10)","DOI":"10.1111\/ctr.13062"},{"key":"184_CR11","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s12185-016-2164-2","volume":"105","author":"E Atilla","year":"2017","unstructured":"Atilla E, Atilla Ataca P, Demirer T (2017c) Current treatment strategies in relapsed\/refractory mantle cell lymphoma: where are we now? Int J Hematol 105:257\u2013264","journal-title":"Int J Hematol"},{"key":"184_CR12","doi-asserted-by":"crossref","unstructured":"Attal M, Harousseau JL, Facon T et al. InterGroupe Francophone du My\u00e9lome (2003) Single versus double autologous stem-cell transplantation for multiple myeloma. N Engl J Med 349(26):2495\u20132502","DOI":"10.1056\/NEJMoa032290"},{"key":"184_CR13","doi-asserted-by":"crossref","unstructured":"Attal M, Lauwers-Cances V, Marit G et al. IFM Investigators (2012) Lenalidomide maintenance after stem-cell transplantation for multiple myeloma. N Engl J Med 366(19):1782\u20131791","DOI":"10.1056\/NEJMoa1114138"},{"key":"184_CR14","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1093\/annonc\/mdg496","volume":"14","author":"T Baetz","year":"2003","unstructured":"Baetz T, Belch A, Couban S et al (2003) Gemcitabine, dexamethasone and cisplatin is an active and non-toxic chemotherapy regimen in relapsed or refractory Hodgkin\u2019s disease: a phase II study by the National Cancer Institute of Canada Clinical Trials Group. Ann Oncol 14:1762\u20131767","journal-title":"Ann Oncol"},{"key":"184_CR15","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1038\/bmt.2011.170","volume":"47","author":"SM Bakanay","year":"2012","unstructured":"Bakanay SM, Demirer T (2012) Novel agents and approaches for stem cell mobilization in normal donors and patients. Bone Marrow Transplant 47:1154\u20131163","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"184_CR16","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/bjh.13926","volume":"173","author":"KK Ballen","year":"2016","unstructured":"Ballen KK, Lazarus H (2016) Cord blood transplant for acute myeloid leukaemia. Br J Haematol 173(1):25\u201336","journal-title":"Br J Haematol"},{"key":"184_CR17","doi-asserted-by":"crossref","first-page":"4354","DOI":"10.1200\/JCO.2005.05.105","volume":"23","author":"LM Barker","year":"2005","unstructured":"Barker LM, Pendergrass TW, Sanders JE et al (2005) Survival after recurrence of Ewing\u2019s sarcoma family of tumors. J Clin Oncol 23:4354\u20134362","journal-title":"J Clin Oncol"},{"issue":"6","key":"184_CR18","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1200\/JCO.2005.04.5807","volume":"24","author":"B Barlogie","year":"2006","unstructured":"Barlogie B, Kyle RA, Anderson KC et al (2006) Standard chemotherapy compared with high-dose chemoradiotherapy for multiple myeloma: final results of phase III US Intergroup Trial S9321. J Clin Oncol 24(6):929\u2013936","journal-title":"J Clin Oncol"},{"issue":"26","key":"184_CR19","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1200\/JCO.2017.72.8428","volume":"35","author":"A Bashey","year":"2017","unstructured":"Bashey A, Zhang MJ, McCurdy SR et al (2017) Mobilized peripheral blood stem cells versus unstimulated bone marrow as a graft source for T-cell-replete Haploidentical donor transplantation using post-transplant cyclophosphamide. J Clin Oncol 35(26):3002\u20133009","journal-title":"J Clin Oncol"},{"issue":"6","key":"184_CR20","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1002\/ijc.25149","volume":"127","author":"JO Bay","year":"2010","unstructured":"Bay JO, Cabrespine-Faugeras A, Tabrizi R et al (2010) Allogeneic stem cell transplantation in ovarian cancer. The EBMT experience. Int J Cancer 127(6):1446\u20131452","journal-title":"Int J Cancer"},{"issue":"3","key":"184_CR21","first-page":"527","volume":"18","author":"WI Bensinger","year":"1996","unstructured":"Bensinger WI, Demirer T, Buckner CD et al (1996) Syngeneic marrow transplantation in patients with multiple myeloma. Bone Marrow Transplant 18(3):527\u2013531","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"184_CR22","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1056\/NEJM200101183440303","volume":"344","author":"WI Bensinger","year":"2001","unstructured":"Bensinger WI, Martin PJ, Storer B et al (2001) Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers. N Engl J Med 344(3):175\u2013181","journal-title":"N Engl J Med"},{"key":"184_CR23","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1365-2141.2010.08228.x","volume":"150","author":"SH Bernstein","year":"2010","unstructured":"Bernstein SH, Epner E, Unger JM (2010) A phase II multicenter trial of hyperCVAD MTX\/Ara-C and rituximab in patients with previously untreated mantle cell lymphoma; SWOG 0213. Br J Haematol 150:200\u2013208","journal-title":"Br J Haematol"},{"issue":"24","key":"184_CR24","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1200\/JCO.2010.32.5936","volume":"29","author":"DA Berry","year":"2011","unstructured":"Berry DA, Ueno NT, Johnson MM et al (2011) High-dose chemotherapy with autologous hematopoietic stem-cell transplantation in metastatic breast cancer: overview of six randomized trials. J Clin Oncol 29(24):3224\u20133231","journal-title":"J Clin Oncol"},{"issue":"1","key":"184_CR25","first-page":"131","volume":"18","author":"MW Brunvand","year":"1996","unstructured":"Brunvand MW, Bensinger WI, Soll E et al (1996) High-dose fractionated total-body irradiation, etoposide and cyclophosphamide for treatment of malignant lymphoma: comparison of autologous bone marrow and peripheral blood stem cells. Bone Marrow Transplant 18(1):131\u2013141","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"184_CR26","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1200\/JCO.1993.11.8.1482","volume":"11","author":"S Burdach","year":"1993","unstructured":"Burdach S, Jurgens H, Peters C et al (1993) Myeloablative radiochemotherapy and hematopoietic stem-cell rescue in poor-prognosis Ewing\u2019s sarcoma. J Clin Oncol 11(8):1482","journal-title":"J Clin Oncol"},{"issue":"2","key":"184_CR27","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1136\/jnnp-2017-316271","volume":"89","author":"J Burman","year":"2018","unstructured":"Burman J, Tolf A, H\u00e4gglund H et al (2018) Autologous haematopoietic stem cell transplantation for neurological diseases. J Neurol Neurosurg Psychiatry 89(2):147\u2013155","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"7540","key":"184_CR28","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/nature14242","volume":"518","author":"K Busch","year":"2015","unstructured":"Busch K, Klapproth K, Barile M et al (2015) Fundamental properties of unperturbed haematopoiesis from stem cells in vivo. Nature 518(7540):542\u2013546","journal-title":"Nature"},{"issue":"12","key":"184_CR29","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.clml.2017.10.007","volume":"17","author":"F Cabanillas","year":"2017","unstructured":"Cabanillas F, Shah B (2017) Advances in diagnosis and management of diffuse Large B-cell lymphoma. Clin Lymphoma Myeloma Leuk 17(12):783\u2013796","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"3","key":"184_CR30","first-page":"500","volume":"M35","author":"C Cao","year":"2017","unstructured":"Cao C, Wang M, Sun J et al (2017) Autologous peripheral blood haematopoietic stem cell transplantation for systemic lupus erythematosus: the observation of long-term outcomes in a Chinese centre. Clin Exp Rheumatol M35(3):500\u2013507","journal-title":"Clin Exp Rheumatol"},{"issue":"22","key":"184_CR31","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1182\/blood.V128.22.991.991","volume":"128","author":"M Cavo","year":"2016","unstructured":"Cavo M, Petrucci MT, Raimondo DF et al (2016) Upfront single versus double autologous stem cell transplantation for newly diagnosed multiple myeloma: an intergroup, multicenter, phase III study of the European myeloma network (EMN02\/HO95 MM Trial). Blood 128(22):991","journal-title":"Blood"},{"key":"184_CR32","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1182\/blood.V73.2.606.bloodjournal732606","volume":"73","author":"RE Champlin","year":"1989","unstructured":"Champlin RE, Horowitz M, van Bekkum DW et al (1989) Graft failure following bone marrow transplantation for severe aplastic anemia: risk factors and treatment results. Blood 73:606\u2013613","journal-title":"Blood"},{"key":"184_CR33","unstructured":"Clinical Practice Guidelines in Oncology. National Comprehensive Cancer Network, v2. 2016, 2016. at http:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/testicular.pdf"},{"key":"184_CR34","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1038\/sj.leu.2404306","volume":"20","author":"P Corradini","year":"2006","unstructured":"Corradini P, Tarella C, Zallio F et al (2006) Long-term follow-up of patients with peripheral T-cell lymphomas treated up-front with high-dose chemotherapy followed by autologous stem cell transplantation. Leukemia 20:1533\u20131538","journal-title":"Leukemia"},{"issue":"16","key":"184_CR35","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1182\/blood-2017-03-769620","volume":"130","author":"M Crump","year":"2017","unstructured":"Crump M, Neelapu SS, Farooq U et al (2017) Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study. Blood 130(16):1800\u20131808","journal-title":"Blood"},{"key":"184_CR36","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1200\/JCO.2011.40.2719","volume":"30","author":"F D\u2019Amore","year":"2012","unstructured":"D\u2019Amore F, Relander T, Lauritzsen G et al (2012) Up-front autologous stem cell transplantation in peripheral T-cell lymphoma : NLG-T-01. J Clin Oncol 30:3093\u20133099","journal-title":"J Clin Oncol"},{"key":"184_CR37","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.stem.2009.02.009","volume":"4","author":"GQ Daley","year":"2009","unstructured":"Daley GQ, Lensch W, Jaenisch R et al (2009) Broader implications of defining standards for the pluripotency of iPSCs. Cell Stem Cell 4:200","journal-title":"Cell Stem Cell"},{"issue":"4","key":"184_CR38","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/sj.bjc.6602724","volume":"93","author":"U Giorgi De","year":"2005","unstructured":"De Giorgi U, Rosti G, Slavin S et al (2005a) Salvage high-dose chemotherapy for children with extragonadal germ-cell tumors. Group authors: European grp blood marrow transplantation. Br J Cancer 93(4):412\u2013441","journal-title":"Br J Cancer"},{"issue":"1","key":"184_CR39","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/annonc\/mdi017","volume":"16","author":"U Giorgi De","year":"2005","unstructured":"De Giorgi U, Demirer T, Wandt H et al (2005b) Second-line high-dose chemotherapy in patients with mediastinal and retroperitoneal primary non-seminomatous germ cell tumors: the EBMT experience. Ann Oncol 16(1):146\u2013151","journal-title":"Ann Oncol"},{"key":"184_CR40","doi-asserted-by":"crossref","unstructured":"Demirer T Preface (eds) (2017) In Haploidentical stem cell transplantation: an emerging treatment modality. Humana Press\/Springer International Publishing, Cham","DOI":"10.1007\/978-3-319-65319-8"},{"issue":"6","key":"184_CR41","first-page":"907","volume":"15","author":"T Demirer","year":"1995","unstructured":"Demirer T, Gooley T, Buckner CD et al (1995a) Influence of total nucleated cell dose from marrow harvests on outcome in patients with acute myelogenous leukemia undergoing autologous transplantation. Bone Marrow Transplant 15(6):907\u2013913","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"184_CR42","first-page":"915","volume":"15","author":"T Demirer","year":"1995","unstructured":"Demirer T, Buckner CD, Petersen FB et al (1995b) Rapid engraftment after autologous transplantation utilizing marrow and recombinant granulocyte-colony stimulating factor (G-CSF) mobilized peripheral blood stem cells in patients with acute myelogenous leukemia. Bone Marrow Transplant 15(6):915\u2013922","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"184_CR43","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1200\/JCO.1995.13.3.596","volume":"13","author":"T Demirer","year":"1995","unstructured":"Demirer T, Weaver CH, Buckner CD et al (1995c) High-dose, carmustine, and etoposide (CBV) followed by allogeneic bone marrow transplantation cyclophosphamide in patients with lymphoid malignancies who had received dose-limiting radiation therapy. J Clin Oncol 13(3):596\u2013602","journal-title":"J Clin Oncol"},{"issue":"4","key":"184_CR44","first-page":"491","volume":"17","author":"T Demirer","year":"1996","unstructured":"Demirer T, Buckner CD, Appelbaum FR et al (1996a) Busulfan, cyclophosphamide and fractionated total body irradiation for autologous or syngeneic marrow transplantation for acute and chronic myelogenous leukemia: Phase I dose escalation of busulfan based on targeted plasma levels. Bone Marrow Transplant 17(4):491\u2013495","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"184_CR45","first-page":"341","volume":"17","author":"T Demirer","year":"1996","unstructured":"Demirer T, Buckner CD, Appelbaum FR et al (1996b) Busulfan, cyclophosphamide and fractionated total body irradiation for allogeneic marrow transplantation in advanced acute and chronic myelogenous leukemia: phase I dose escalation of busulfan based on targeted plasma levels. Bone Marrow Transplant 17(3):341\u2013346","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"184_CR46","first-page":"29","volume":"18","author":"T Demirer","year":"1996","unstructured":"Demirer T, Petersen FB, Bensinger WI et al (1996c) Autologous transplantation with peripheral blood stem cells collected after granulocyte colony-stimulating factor in patients with acute myelogenous leukemia. Bone Marrow Transplant 18(1):29\u201334","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"184_CR47","first-page":"769","volume":"17","author":"T Demirer","year":"1996","unstructured":"Demirer T, Buckner CD, Appelbaum FR et al (1996d) High-dose busulfan and cyclophosphamide followed by autologous transplantation in patients with advanced breast cancer. Bone Marrow Transplant 17(5):769\u2013774","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"184_CR48","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/sj.bmt.1701902","volume":"24","author":"T Demirer","year":"1999","unstructured":"Demirer T, Celebi H, Arat M et al (1999) Autoimmune thrombocytopenia in a patient with small cell lung cancer developing after chemotherapy and resolving following autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 24(3):335\u2013337","journal-title":"Bone Marrow Transplant"},{"key":"184_CR49","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/jca.1015","volume":"16","author":"T Demirer","year":"2001","unstructured":"Demirer T, Ilhan O, Arat M et al (2001) CD41+ and CD42+ hematopoietic progenitor cells predict platelet engraftment after allogeneic peripheral blood stem cell transplantation. J Clin Apher 16:67\u201373","journal-title":"J Clin Apher"},{"issue":"5","key":"184_CR50","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1046\/j.1526-0968.2002.00406.x","volume":"6","author":"T Demirer","year":"2002","unstructured":"Demirer T, \u0130lhan O, Ayl\u0131 M, Arat M et al (2002) Monitoring of peripheral blood CD34+ cell counts on the first day of apheresis is highly predictive for efficient CD34+ cell yield. Ther Apher 6(5):384\u2013389","journal-title":"Ther Apher"},{"key":"184_CR51","doi-asserted-by":"publisher","unstructured":"Dhakal B, Szabo A, Chhabra S et al (2018) Autologous transplantation for newly diagnosed multiple myeloma in the era of novel agent induction: a systematic review and meta-analysis. JAMA Oncol. https:\/\/doi.org\/10.1001\/jamaoncol.2017.4600","DOI":"10.1001\/jamaoncol.2017.4600"},{"issue":"4","key":"184_CR52","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","volume":"129","author":"H D\u00f6hner","year":"2017","unstructured":"D\u00f6hner H, Estey E, Grimwade D et al (2017) Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood 129(4):424\u2013447","journal-title":"Blood"},{"key":"184_CR53","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1182\/blood-2004-10-3883","volume":"105","author":"M Dreyling","year":"2005","unstructured":"Dreyling M, Lenz G, Hoster E et al (2005) Early consolidation by myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission significantly prolongs progression-free survival in mantle-cell lymphoma: results of a prospective randomized trial of the European MCL Network. Blood 105:2677\u20132684","journal-title":"Blood"},{"key":"184_CR54","doi-asserted-by":"publisher","unstructured":"Eyraud A, Scouppe L, Barnetche T et al. FHU ACRONIM (2017) Efficacy and safety of autologous haematopoietic stem cell transplantation in systemic sclerosis: A systematic review of literature. Br J Dermatol. https:\/\/doi.org\/10.1111\/bjd.15993","DOI":"10.1111\/bjd.15993"},{"key":"184_CR55","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1200\/JCO.2013.49.2454","volume":"32","author":"TS Fenske","year":"2014","unstructured":"Fenske TS, Zhang MJ, Carreras J et al (2014) Autologous or reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chemotherapy-sensitive mantle-cell lymphoma: analysis of transplantation timing and modality. J Clin Oncol 32:273\u2013281","journal-title":"J Clin Oncol"},{"key":"184_CR56","doi-asserted-by":"crossref","unstructured":"Fermand JP, Katsahian S, Divine M, et al. Group Myelome-Autogreffe (2005) High-dose therapy and autologous blood stem-cell transplantation compared with conventional treatment in myeloma patients aged 55 to 65 years: long-term results of a randomized control trial from the Group Myelome-Autogreffe. J Clin Oncol 23(36):9227\u20139233","DOI":"10.1200\/JCO.2005.03.0551"},{"key":"184_CR01","doi-asserted-by":"crossref","unstructured":"Ferraro F, Celso CL et al (2010) Adult stem cells and their niches. Adv Exp Med Biol 695:155\u2013168","DOI":"10.1007\/978-1-4419-7037-4_11"},{"key":"184_CR58","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1200\/JCO.1998.16.1.13","volume":"16","author":"AS Freedman","year":"1998","unstructured":"Freedman AS, Neuberg D, Gribben JG et al (1998) High-dose chemoradiotherapy and anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation in mantle-cell lymphoma: no evidence for long-term remission. J Clin Oncol 16:13\u201318","journal-title":"J Clin Oncol"},{"key":"184_CR59","doi-asserted-by":"crossref","first-page":"5055","DOI":"10.1182\/blood-2012-11-469452","volume":"121","author":"G Gahrton","year":"2013","unstructured":"Gahrton G, Iacobelli S, Bjorkstrand B et al (2013) Autologous\/reduced-intensity allogeneic stem cell transplantation vs autologous transplantation in multiple myeloma: long-term results of the EBMT- NMAM2000 study. Blood 121:5055\u20135063","journal-title":"Blood"},{"key":"184_CR60","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/bmt.2012.275","volume":"48","author":"RP Gale","year":"2013","unstructured":"Gale RP, Lazarus HM (2013) A rose by any other name would smell as sweet\u2019, or would it? Bone Marrow Transplant 48:881\u2013883","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"184_CR61","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.retram.2017.08.003","volume":"65","author":"J Gauthier","year":"2017","unstructured":"Gauthier J, Yakoub-Agha I (2017) Chimeric antigen-receptor T-cell therapy for hematological malignancies and solid tumors: clinical data to date, current limitations and perspectives. Curr Res Transl Med 65(3):93\u2013102","journal-title":"Curr Res Transl Med"},{"issue":"24","key":"184_CR62","doi-asserted-by":"crossref","first-page":"6721","DOI":"10.1182\/blood-2011-03-339945","volume":"117","author":"L Giaccone","year":"2011","unstructured":"Giaccone L, Storer B, Patriarca F et al (2011) Long-term follow-up of a comparison of nonmyeloablative allografting with autografting for newly diagnosed myeloma. Blood 117(24):6721\u20136727","journal-title":"Blood"},{"issue":"12","key":"184_CR63","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/sj.bmt.1704704","volume":"34","author":"UD Giorgi","year":"2004","unstructured":"Giorgi UD, Wandt H, Lioure B et al (2004) First-line high-dose chemotherapy for patients with poor prognosis extragonadal germ cell tumors. The experience of the European Bone Marrow Transplantation (EBMT) solid tumors working party. Bone Marrow Transplant 34(12):1033\u20131037","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"184_CR64","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.critrevonc.2013.08.016","volume":"89","author":"M Gkotzamanidou","year":"2014","unstructured":"Gkotzamanidou M, Papadimitriou CA (2014) Peripheral T-cell lymphoma: the role of hematopoietic stem cell transplantation. Crit Rev Oncol Hematol 89(2):248\u2013261","journal-title":"Crit Rev Oncol Hematol"},{"key":"184_CR65","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1200\/JCO.2012.43.4803","volume":"31","author":"LI Gordon","year":"2003","unstructured":"Gordon LI, Hong F, Fisher RI et al (2003) Randomized phase III trial of ABVD versus Stanford V with or without radiation therapy in locally extensive and advanced-stage Hodgkin lymphoma: an intergroup study coordinated by the Eastern Cooperative Oncology Group. J Clin Oncol 31:684\u2013691","journal-title":"J Clin Oncol"},{"issue":"4","key":"184_CR66","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1093\/annonc\/mdh142","volume":"15","author":"A Gratwohl","year":"2004","unstructured":"Gratwohl A, Baldomero H, Demirer T et al (2004) Hematopoietic stem cell transplantation for solid tumors in Europe. EBMT; STWP; PDWP. Ann Oncol 15(4):653\u2013660","journal-title":"Ann Oncol"},{"issue":"2","key":"184_CR67","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2174\/157488808784223032","volume":"3","author":"TJ Heino","year":"2008","unstructured":"Heino TJ, Hentunen TA (2008) Differentiation of osteoblasts and osteocytes from mesenchymal stem cells. Curr Stem Cell Res Ther 3(2):131\u2013145","journal-title":"Curr Stem Cell Res Ther"},{"key":"184_CR68","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.expneurol.2003.11.005","volume":"186","author":"DC Hess","year":"2004","unstructured":"Hess DC, Abe T, Hill WD et al (2004) Hematopoietic origin of microglial and perivascular cells in brain. Exp Neurol 186:134\u2013144","journal-title":"Exp Neurol"},{"key":"184_CR69","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/sj.bmt.1701398","volume":"22","author":"LA Holmberg","year":"1998","unstructured":"Holmberg LA, Demirer T, Rowley S et al (1998) High-dose busulfan, melphalan and thiotepa followed by autologous peripheral blood stem cell (PBSC) rescue in patients with advanced stage III-IV ovarian cancer. Bone Marrow Transplant 22:651\u2013659","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"184_CR70","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/MOH.0b013e328360ab4d","volume":"20","author":"P Hsu","year":"2013","unstructured":"Hsu P, Qu CK (2013) Metabolic Plasticity and Hematopoietic Stem Cell Biology. Curr Opin Hematol 20(4):289\u2013294. https:\/\/stemcells.nih.gov\/info\/2001report\/chapter4.htm#Holtzer (Adult Stem Cells). -https:\/\/www.cibmtr.org\/ReferenceCenter\/SlidesReports\/SummarySlides\/Pages\/index.aspx (CIBMTR data)","journal-title":"Curr Opin Hematol"},{"issue":"5","key":"184_CR71","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1177\/2040620714547327","volume":"5","author":"W Iams","year":"2014","unstructured":"Iams W, Reddy NM (2014) Consolidative autologous hematopoietic stem-cell transplantation in first remission for non-Hodgkin lymphoma: current indications and future perspective. Ther Adv Hematol 5(5):153\u2013167","journal-title":"Ther Adv Hematol"},{"key":"184_CR72","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.bbmt.2011.10.044","volume":"18","author":"VH Jimenez-Zepeda","year":"2012","unstructured":"Jimenez-Zepeda VH, Mikhael J et al (2012) Second autologous stem cell transplantation as salvage therapy for multiple myeloma: impact on progression-free and overall survival. Biol Blood Marrow Transplant 18:773\u2013779","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"184_CR73","first-page":"306","volume":"22","author":"N Karadurmu\u015f","year":"2017","unstructured":"Karadurmu\u015f N, \u015eahin U, Arpac\u0131 F, Demirer T (2017) An overview of high dose chemotherapy with autologous stem cell rescue for germ cell tumors in current practice. Balkan Union Oncol 22(2):306\u2013311","journal-title":"Balkan Union Oncol"},{"issue":"12","key":"184_CR74","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1038\/sj.bmt.1704291","volume":"32","author":"N Kroger","year":"2003","unstructured":"Kroger N, Damon L, Zander AR et al (2003) Secondary acute leukemia following mitoxantrone-based high-dose chemotherapy for primary breast cancer patients. Bone Marrow Transplant 32(12):1153\u20131115","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"184_CR75","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.blre.2004.03.001","volume":"19","author":"U Lakshmipathy","year":"2005","unstructured":"Lakshmipathy U, Verfaillie C (2005) Stem cell plasticity. Blood Rev 19(1):29\u201338","journal-title":"Blood Rev"},{"key":"184_CR76","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/cne.20929","volume":"496","author":"H Lang","year":"2006","unstructured":"Lang H, Ebihara Y, Schmiedt RA et al (2006) Contribution of bone marrow hematopoietic stem cells to adult mouse inner ear: mesenchymal cells and fibrocytes. J Comp Neurol 496:187\u2013201","journal-title":"J Comp Neurol"},{"issue":"4","key":"184_CR77","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/sj.leu.2402406","volume":"16","author":"F Lefr\u00e8re","year":"2002","unstructured":"Lefr\u00e8re F, Delmer A, Suzan F et al (2002) Sequential chemotherapy by CHOP and DHAP regimens followed by high-dose therapy with stem cell transplantation induces a high rate of complete response and improves event free survival in mantle cell lymphoma: a prospective study. Leukemia 16(4):587\u2013593","journal-title":"Leukemia"},{"issue":"3","key":"184_CR78","first-page":"494","volume":"35","author":"XM Leng","year":"2017","unstructured":"Leng XM, Jiang Y, Zhou DB et al (2017) Good outcome of severe lupus patients with high-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation: a 10-year follow-up study. Clin Exp Rheumatol 35(3):494\u2013499","journal-title":"Clin Exp Rheumatol"},{"key":"184_CR79","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/leu.2013.220","volume":"28","author":"S Lonial","year":"2014","unstructured":"Lonial S, Anderson KC (2014) Association of response endpoints with survival outcomes in multiple myeloma. Leukemia 28:258\u2013268","journal-title":"Leukemia"},{"issue":"11","key":"184_CR80","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1016\/j.bbmt.2015.07.032","volume":"21","author":"NS Majhail","year":"2015","unstructured":"Majhail NS, Farnia SH, Carpenter PA et al (2015) Indications for autologous and allogeneic hematopoietic cell transplantation: guidelines from the American Society for Blood and Marrow Transplantation. Biol Blood Marrow Transplant 21(11):1863\u20131869","journal-title":"Biol Blood Marrow Transplant"},{"key":"184_CR81","unstructured":"Mancardi GL, Sormani MP, Gualandi F et al. ASTIMS Haemato-Neurological Collaborative Group, On behalf of the Autoimmune Disease Working Party (ADWP) of the European Group for Blood and Marrow Transplantation (EBMT); ASTIMS Haemato-Neurological Collaborative Group On behalf of the Autoimmune Disease Working Party ADWP of the European Group for Blood and Marrow Transplantation EBMT (2015) Autologous hematopoietic stem cell transplantation in multiple sclerosis: a phase II trial. Neurology 84(10):981\u2013988"},{"key":"184_CR82","doi-asserted-by":"crossref","unstructured":"Mancardi G, Sormani MP, Muraro PA et al (2018) Intense immunosuppression followed by autologous haematopoietic stem cell transplantation as a therapeutic strategy in aggressive forms of multiple sclerosis. Mult Scler 24(3):245\u2013255","DOI":"10.1177\/1352458517742532"},{"key":"184_CR83","unstructured":"Marco B (2012) Solid tumours in adults. In: Apperley J, Carreras E, Gluckman E, Masszi T (eds) EBMT-ESH handbook on Haematopoietic stem cell transplantation, 6th edn. European School of Haematology pp 526\u2013538"},{"key":"184_CR84","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1182\/blood-2002-02-0506","volume":"100","author":"DI Marks","year":"2002","unstructured":"Marks DI, Lush R, Cavenagh J et al (2002) The toxicity and efficacy of donor lymphocyte infusions given after reduced-intensity conditioning allogeneic stem cell transplantation. Blood 100:3108\u20133114","journal-title":"Blood"},{"issue":"6","key":"184_CR85","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1177\/096120339700600613","volume":"6","author":"AM Marmont","year":"1997","unstructured":"Marmont AM, van Lint MT, Gualandi F et al (1997) Autologous marrow stem cell transplantation for severe systemic lupus erythematosus of long duration. Lupus 6(6):545\u2013548","journal-title":"Lupus"},{"issue":"2","key":"184_CR86","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1002\/jcp.26037","volume":"233","author":"D Mattiucci","year":"2018","unstructured":"Mattiucci D, Maurizi G, Izzi V et al (2018) Bone marrow adipocytes support hematopoietic stem cell survival. J Cell Physiol 233(2):1500\u20131511","journal-title":"J Cell Physiol"},{"issue":"29","key":"184_CR87","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1200\/JCO.2017.72.6679","volume":"35","author":"PL McCarthy","year":"2017","unstructured":"McCarthy PL, Holstein SA, Petrucci MT et al (2017) Lenalidomide maintenance after autologous stem-cell transplantation in newly diagnosed multiple myeloma: a meta-analysis. J Clin Oncol 35(29):3279\u20133289","journal-title":"J Clin Oncol"},{"key":"184_CR88","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1093\/annonc\/mdl108","volume":"17","author":"A McTiernan","year":"2006","unstructured":"McTiernan A, Driver D, Michelagnoli MP et al (2006) High dose chemotherapy with bone marrow or peripheral stem cell rescue is an effective treatment option for patients with relapsed or progressive Ewing\u2019s sarcoma family of tumours. Ann Oncol 17:1301\u20131305","journal-title":"Ann Oncol"},{"issue":"1","key":"184_CR89","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.bcmd.2012.08.003","volume":"50","author":"M Mehrotra","year":"2013","unstructured":"Mehrotra M, Williams CR, Ogawa M et al (2013) Hematopoietic stem cells give rise to osteo-chondrogenic cells. Blood Cells Mol Dis 50(1):41\u201349","journal-title":"Blood Cells Mol Dis"},{"key":"184_CR90","doi-asserted-by":"crossref","unstructured":"Nagler A, Labopin M, Shimoni A, et al. ALWP-EBMT (2012) Mobilized peripheral blood stem cells compared with bone marrow from HLA-identical siblings for reduced-intensity conditioning transplantation in acute myeloid leukemia in complete remission: a retrospective analysis from the Acute Leukemia working party of EBMT. Eur J Haematol 89(3):206\u201313","DOI":"10.1111\/j.1600-0609.2012.01811.x"},{"key":"184_CR91","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1182\/blood-2006-04-016600","volume":"108","author":"M Ogawa","year":"2006","unstructured":"Ogawa M, LaRue AC, Drake CJ (2006) Hematopoietic origin of fibroblasts\/myofibroblasts: its pathophysiologic implications. Blood 108:2893\u20132896","journal-title":"Blood"},{"issue":"1","key":"184_CR92","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.bcmd.2013.01.008","volume":"51","author":"M Ogawa","year":"2013","unstructured":"Ogawa M, LaRue A, Mehrotra M (2013) Hematopoietic stem cells are pluripotent and not just \u201chematopoietic\u201d. Blood Cells Mol Dis 51(1):3\u20138","journal-title":"Blood Cells Mol Dis"},{"issue":"6","key":"184_CR93","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/bmt.2016.20","volume":"51","author":"JR Passweg","year":"2016","unstructured":"Passweg JR, Baldomero H, Bader P et al (2016) Hematopoietic stem cell transplantation in Europe 2014: more than 40.000 transplants annually. Bone Marrow Transplant 51(6):786\u2013792","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"184_CR94","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/bmt.2017.34","volume":"52","author":"JR Passweg","year":"2017","unstructured":"Passweg JR, Baldomero H, Bader P et al (2017) Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report. Bone Marrow Transplant 52(6):811\u2013817","journal-title":"Bone Marrow Transplant"},{"key":"184_CR95","doi-asserted-by":"crossref","unstructured":"Peccatori J, Barkholt L, Demirer T et al. on behalf of EBMT (2005) Prognostic factors for survival in patients with advanced renal cell carcinoma undergoing nonmyeloablative allogeneic stem cell transplantation. Cancer 104(10):2099\u20132103","DOI":"10.1002\/cncr.21477"},{"issue":"5","key":"184_CR96","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/sj.bmt.1704153","volume":"32","author":"P Pedrazzoli","year":"2003","unstructured":"Pedrazzoli P, Ferrante P, Kulekci A et al (2003) Autologous hematopoietic stem cell transplantation for breast cancer in Europe: critical evaluation of data from the European Group for Blood and Marrow Transplantation (EBMT) Registry 1990-1999. Bone Marrow Transplant 32(5):489\u2013494","journal-title":"Bone Marrow Transplant"},{"issue":"10","key":"184_CR97","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1093\/annonc\/mdl044","volume":"17","author":"P Pedrazzoli","year":"2006","unstructured":"Pedrazzoli P, Ledermann JA, Lotz J-P et al (2006) Group author(s): European grp blood marrow transplant. High dose chemotherapy with autologous hematopoietic stem cell support for solid tumors other than breast cancer in adults. Ann Oncol 17(10):1479\u20131488","journal-title":"Ann Oncol"},{"issue":"23","key":"184_CR98","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1056\/NEJM199512073332305","volume":"333","author":"T Philip","year":"1995","unstructured":"Philip T, Guglielmi C, Hagenbeek A et al (1995) Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy- sensitive non-Hodgkin\u2019s lymphoma. N Engl J Med 333(23):1540\u20131545","journal-title":"N Engl J Med"},{"key":"184_CR99","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1056\/NEJMe1511947","volume":"373","author":"J Radford","year":"2015","unstructured":"Radford J, Illidge T, Barrington S (2015) PET-directed therapy for Hodgkin\u2019s lymphoma. N Engl J Med 373:392","journal-title":"N Engl J Med"},{"key":"184_CR100","doi-asserted-by":"crossref","unstructured":"Ray P, De A, Yaghoubi S, Khanna A (2015) Application of adult stem cells in medicine. Stem Cells Int. Article ID 258313, 2","DOI":"10.1155\/2015\/258313"},{"key":"184_CR101","doi-asserted-by":"crossref","unstructured":"van Rhijn-Brouwer FCC, Spierings J, van Laar JM (2017) Autologous hematopoietic stem cell transplantation in systemic sclerosis: a reset to tolerance? Immunol Lett Nov 16","DOI":"10.1016\/j.imlet.2017.11.005"},{"key":"184_CR102","doi-asserted-by":"crossref","unstructured":"Ringd\u00e9n O, Labopin M, Beelen DW et al. Acute Leukaemia Working Party of European Group for Blood and Marrow Transplantation (EBMT) (2012) Bone marrow or peripheral blood stem cell transplantation from unrelated donors in adult patients with acute myeloid leukaemia, an Acute Leukaemia Working Party analysis in 2262 patients. J Intern Med 272(5): 472\u201383","DOI":"10.1111\/j.1365-2796.2012.02547.x"},{"key":"184_CR103","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1172\/JCI10256","volume":"105","author":"PG Robey","year":"2000","unstructured":"Robey PG (2000) Stem cells near the century mark. J Clin Invest 105:1489\u20131491","journal-title":"J Clin Invest"},{"key":"184_CR104","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/leu.2014.223","volume":"29","author":"S Robinson","year":"2015","unstructured":"Robinson S, Dreger P, Caballero D et al (2015) The EBMT\/EMCL consensus project on the role of autologous and allogeneic stem cell transplantation in mantle cell lymphoma. Leukemia 29:464\u2013473","journal-title":"Leukemia"},{"key":"184_CR105","doi-asserted-by":"crossref","unstructured":"Rosi\u00f1ol L, P\u00e9rez-Sim\u00f3n JA, Sureda A et al. Programa para el Estudio y la Terap\u00e9utica de las Hemopat\u00edas Malignas y Grupo Espa\u00f1ol de Mieloma (PETHEMA\/GEM)(2008) A prospective PETHEMA study of tandem autologous transplantation versus autograft followed by reduced-intensity conditioning allogeneic transplantation in newly diagnosed multiple myeloma. Blood 112(9):3591\u20133","DOI":"10.1182\/blood-2008-02-141598"},{"key":"184_CR106","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/978-3-319-65319-8_13","volume-title":"Haploidentical stem cell transplantation: an emerging treatment modality","author":"U Sahin","year":"2017","unstructured":"Sahin U, Demirer T (2017) Chapter 13: Future perspectives for Haploidentical stem cell transplantation. In: Demirer T (ed) Haploidentical stem cell transplantation: an emerging treatment modality. Humana Press\/Springer, Cham, pp 189\u2013199"},{"key":"184_CR107","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jiac.2016.05.006","volume":"22","author":"U Sahin","year":"2016","unstructured":"Sahin U, Toprak SK, Atilla Ataca P et al (2016a) An overview of infectious complications after allogeneic hematopoietic stem cell transplantation. J Infect Chemother 22:505\u2013514","journal-title":"J Infect Chemother"},{"key":"184_CR108","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.critrevonc.2016.09.004","volume":"107","author":"U Sahin","year":"2016","unstructured":"Sahin U, Atilla Ataca P, Atilla E et al (2016b) An overview of hematopoietic stem cell transplantation related thrombotic complications. Crit Rev Oncol Hematol 107:149\u2013155","journal-title":"Crit Rev Oncol Hematol"},{"issue":"10","key":"184_CR109","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1001\/jamaneurol.2014.1297","volume":"71","author":"S Sanders","year":"2014","unstructured":"Sanders S, Bredeson C, Pringle CE et al (2014) Autologous stem cell transplantation for stiff person syndrome: two cases from the Ottawa blood and marrow transplant program. JAMA Neurol 71(10):1296\u20131299","journal-title":"JAMA Neurol"},{"key":"184_CR110","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.3109\/10428194.2015.1083561","volume":"57","author":"S Sasse","year":"2016","unstructured":"Sasse S, Alram M, Muller H et al (2016) Prognostic relevance of DHAP dose-density in relapsed Hodgkin lymphoma: an analysis of the German Hodgkin-study group. Leuk Lymphoma 57:1067\u20131073","journal-title":"Leuk Lymphoma"},{"key":"184_CR111","doi-asserted-by":"crossref","unstructured":"Schmitz N, Beksac M, Hasenclever D et al. European Group for Blood and Marrow Transplantation (2002) Transplantation of mobilized peripheral blood cells to HLA-identical siblings with standard-risk leukemia. Blood 100(3):761\u2013767","DOI":"10.1182\/blood-2001-12-0304"},{"key":"184_CR112","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1200\/JCO.2003.10.023","volume":"21","author":"HC Schouten","year":"2000","unstructured":"Schouten HC, Qian W, Kvaloy S et al (2000) High-dose therapy improves progression-free survival and survival in relapsed follicular non-Hodgkin\u2019s lymphoma: results from the randomized European CUP trial. J Clin Oncol 21:3918\u20133927","journal-title":"J Clin Oncol"},{"key":"184_CR113","doi-asserted-by":"crossref","first-page":"3614","DOI":"10.1200\/JCO.2007.15.5358","volume":"26","author":"C Sebban","year":"2008","unstructured":"Sebban C, Brice P, Delarue R et al (2008) Impact of rituximab and\/or high-dose therapy with autotransplant at time of relapse in patients with follicular lymphoma: a GELA study. J Clin Oncol 26:3614\u20133620","journal-title":"J Clin Oncol"},{"key":"184_CR114","doi-asserted-by":"crossref","first-page":"418","DOI":"10.3324\/haematol.10521","volume":"92","author":"S Secondino","year":"2007","unstructured":"Secondino S, Carrabba MG, Pedrazzoli P et al (2007) Reduced intensity stem cell transplantation for advanced soft tissue sarcomas in adults: a retrospective analysis of the European group for blood and marrow transplantation. Haematologica 92:418\u2013420","journal-title":"Haematologica"},{"key":"184_CR115","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.exphem.2009.06.008","volume":"37","author":"Y Sera","year":"2009","unstructured":"Sera Y, LaRue AC, Moussa O et al (2009) Hematopoietic stem cell origin of adipocytes. Exp Hematol 37:1108\u20131120","journal-title":"Exp Hematol"},{"issue":"24","key":"184_CR116","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1182\/blood-2016-01-631200","volume":"127","author":"P Sonneveld","year":"2016","unstructured":"Sonneveld P, Avet-Loiseau H, Lonial S et al (2016) Treatment of multiple myeloma with high-risk cytogenetics: a consensus of the international myeloma working group. Blood 127(24):2955\u20132962","journal-title":"Blood"},{"key":"184_CR117","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/sj.bmt.1703936","volume":"32","author":"GJ Spangrude","year":"2003","unstructured":"Spangrude GJ (2003) Stem cells and tissue regeneration when is a stem cell really a stem cell? Bone Marrow Transplant 32:7\u201311","journal-title":"Bone Marrow Transplant"},{"key":"184_CR118","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.stem.2011.09.010","volume":"9","author":"T Suda","year":"2011","unstructured":"Suda T, Takubo K, Semenza GL (2011) Metabolic regulation of hematopoietic stem cells in the hypoxic niche. Cell Stem Cell 9:298\u2013310","journal-title":"Cell Stem Cell"},{"issue":"1","key":"184_CR119","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1056\/NEJMoa1703327","volume":"378","author":"KM Sullivan","year":"2018","unstructured":"Sullivan KM, Goldmuntz EA, Keyes-Elstein L et al (2018) SCOT study investigators Myeloablative autologous stem-cell transplantation for severe scleroderma. N Engl J Med 378(1):35\u201347","journal-title":"N Engl J Med"},{"issue":"7522","key":"184_CR120","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/nature13824","volume":"514","author":"J Sun","year":"2014","unstructured":"Sun J, Ramos A, Chapman B et al (2014) Clonal dynamics of native haematopoiesis. Nature 514(7522):322","journal-title":"Nature"},{"issue":"8","key":"184_CR121","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1038\/bmt.2015.6","volume":"50","author":"A Sureda","year":"2015","unstructured":"Sureda A, Bader P, Cesaro S et al (2015) Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe. Bone Marrow Transplant 50(8):1037\u20131056","journal-title":"Bone Marrow Transplant"},{"key":"184_CR122","doi-asserted-by":"crossref","unstructured":"Tessoulin B, Ceballos P, Chevaller P et al (2016) Allogeneic stem cell transplantation for patients with mantle cell lymphoma who failed autologous stem cell transplantation: a national survey of the SFGM-TC. Bone Marrow Transplant:1\u20137","DOI":"10.1038\/bmt.2016.102"},{"issue":"6","key":"184_CR123","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.bbmt.2016.02.010","volume":"22","author":"S Tsai","year":"2016","unstructured":"Tsai S, Liu H, Shore T et al (2016) Frequency and risk factors associated with cord graft failure after transplant with single-unit umbilical cord cells supplemented by Haploidentical cells with reduced-intensity conditioning. Biol Blood Marrow Transplant 22(6):1065\u20131072","journal-title":"Biol Blood Marrow Transplant"},{"key":"184_CR124","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/sj.bmt.1705940","volume":"41","author":"NT Ueno","year":"2008","unstructured":"Ueno NT, Rizzo D, Demirer T et al (2008) Allogeneic hematopoietic cell transplantation for metastatic breast cancer. Bone Marrow Transplant 41:537\u2013545","journal-title":"Bone Marrow Transplant"},{"key":"184_CR125","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1200\/JCO.2010.30.2596","volume":"29","author":"RJ Kampen van","year":"2011","unstructured":"van Kampen RJ, Canals C, Schouten HC et al (2011) Allogeneic stem-cell transplantation as salvage therapy for patients with diffuse large B-cell non-Hodgkin\u2019s lymphoma relapsing after an autologous stem-cell transplantation: an analysis of the European group for blood and marrow transplantation registry. J Clin Oncol 29:1342\u20131348","journal-title":"J Clin Oncol"},{"key":"184_CR126","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1046\/j.1365-2141.2003.04140.x","volume":"120","author":"E Vanderberghe","year":"2003","unstructured":"Vanderberghe E, Elvira CR, Loveriza F et al (2003) Outcome of autologous transplantation for mantle cell lymphoma: a study by the European blood and bone marrow transplant and autologous blood and marrow transplant registries. Br J Haematol 120:793\u2013800","journal-title":"Br J Haematol"},{"issue":"4","key":"184_CR127","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/ncb3493","volume":"19","author":"L Velten","year":"2017","unstructured":"Velten L, Haas SF, Raffel S et al (2017) Human haematopoietic stem cell lineage commitment is a continuous process. Nat Cell Biol 19(4):271\u2013281","journal-title":"Nat Cell Biol"},{"key":"184_CR128","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1161\/01.RES.0000207384.81818.d4","volume":"98","author":"RP Visconti","year":"2006","unstructured":"Visconti RP, Ebihara Y, LaRue AC et al (2006) An in vivo analysis of hematopoietic stem cell potential: hematopoietic origin of cardiac valve interstitial cells. Circ Res 98:690\u2013696","journal-title":"Circ Res"},{"key":"184_CR129","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1126\/science.1064081","volume":"294","author":"DE Wright","year":"2001","unstructured":"Wright DE, Wagers AJ, Gulati AP (2001) Physiological migration of hematopoietic stem and progenitor cells. Science 294:1933\u20131936","journal-title":"Science"},{"issue":"12","key":"184_CR130","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1080\/14737140.2017.1395285","volume":"17","author":"J Xu","year":"2017","unstructured":"Xu J, Tian K, Zhang H, Li L et al (2017) Chimeric antigen receptor-T cell therapy for solid tumors require new clinical regimens. Expert Rev Anticancer Ther 17(12):1099\u20131106","journal-title":"Expert Rev Anticancer Ther"},{"issue":"4","key":"184_CR131","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/icb.2016.128","volume":"95","author":"CSM Yong","year":"2017","unstructured":"Yong CSM, Dardalhon V, Devaud C et al (2017) CAR T-cell therapy of solid tumors. Immunol Cell Biol 95(4):356\u2013363","journal-title":"Immunol Cell Biol"},{"key":"184_CR132","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/978-3-319-65319-8_4","volume-title":"Haploidentical stem cell transplantation: an emerging treatment modality","author":"MK Yuksel","year":"2017","unstructured":"Yuksel MK, Demirer T (2017) Chapter 4: Toxicity of conditioning regimens in haploidentical stem cell transplantation. In: Demirer T (ed) Haploidentical stem cell transplantation: an emerging treatment modality. Humana Press\/Springer, Cham, pp 43\u201356"}],"container-title":["Advances in Experimental Medicine and Biology","Cell Biology and Translational Medicine, Volume 1"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/5584_2018_184","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T03:32:03Z","timestamp":1719891123000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/5584_2018_184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"ISBN":["9783319938660","9783319938677"],"references-count":132,"URL":"https:\/\/doi.org\/10.1007\/5584_2018_184","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}